Compass Therapeutics, Inc.
Clinical-stage biopharma developing antibody-based therapeutics for oncology.
CMPX | US
Overview
Corporate Details
- ISIN(s):
- US20454B1044
- LEI:
- Country:
- United States of America
- Address:
- 80 GUEST STREET, 2135 BOSTON
- Sector:
- Manufacturing
Description
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company that develops proprietary antibody-based therapeutics. The company leverages its proprietary antibody discovery engine and in vitro/in vivo platforms to generate diverse antibody panels. This approach is based on a deep understanding of the tumor microenvironment, aiming to develop product candidates that optimize the immune system's anti-tumor response. The company's mission is to create transformative cancer therapies to improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Compass Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compass Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compass Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
